Dr. Hibah Shaath obtained her Bachelor of Science (Hons) and Master of Research (MRes) degrees in Genetics and Genetic Medicine from the University of Manchester. The focus of her MRes was the biomolecular characterization of Keratoconic corneas associated with transplant rejection. In 2013 she moved to Qatar and joined Shafallah Medical Genetics Center, where her main focus was identifying candidate genes with novel mutations associated with both Mendelian hereditary disease and ASD, through homozygosity mapping and family screening, presented in several posters at ARC’13 and ARC’14. In 2014, Dr. Shaath joined QBRI to work as a Research Associate in the Translational Oncology Research Center. In 2022, she completed her PhD in Biomedical and Biological Sciences from the College of Health and Life Sciences (CHLS) at HBKU under the supervision of Dr. Nehad Alajez. Her research focus is on the transcriptional landscape of colorectal cancer and breast cancer for novel biomarker discovery and targeted therapy. Her research was selected for oral presentation at the first Advances in Precision Medicine (APM 2021) conference at HBKU, and in 2022; her poster was selected for Best Poster Award in the student category as the third place winner at HBKU Research Day.